-
Product Name
Depatuxizumab (Synonyms: ANTI-EGFR MAB ABT-806; ANTI-EGFR MOAB ABT-806)
- Documents
-
Description
Anti-ERBB1 / EGFR / HER1 Antibody (Depatuxizumab)
-
Tested applications
ELISA
-
Species reactivity
Human ERBB1 / EGFR / HER1
-
Alternative names
ANTI-EGFR MAB ABT-806 antibody; ANTI-EGFR MOAB ABT-806 antibody
-
Isotype
IgG1
-
Preparation
Recombinant expression and purified from CHO cells.
-
Clonality
Monoclonal
-
Formulation
0.1 M Pro-Ac, 20 mM Arg, pH 5.0
-
Storage instructions
-80°C for 2 years under sterile conditions; -20°C for 1 year under sterile conditions; Avoid repeated freeze-thaw cycles.
-
Validations
ELISA
Human ERBB1 / EGFR / HER1, His Tag at 2 μg/mL can bind Depatuxizumab ，EC50=0.01559 μg/mL.
SDS-PAGE
Anti-ERBB1 / EGFR / HER1 Antibody (depatuxizumab) on SDS-PAGE under reducing (R) condition. The purity of the protein is greater than 95%.
SEC-HPLC
The purity of Anti-ERBB1 / EGFR / HER1 Antibody (depatuxizumab) is 99.58%, determined by SEC-HPLC.
Bioactivity: FACS
Human EGFR CHO-K cells were stained with Anti-ERBB1 / EGFR / HER1 Antibody (depatuxizumab) and negative control protein respectively, washed and then followed by PE and analyzed with FACS, EC50=34.40 nM.
Related Products / Services
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"